EquiliBio

Mission

Chronic inflammation is sneaky — it quietly raises the risk of everything from cancer to heart disease, pulling the strings behind many of the conditions we accept as “just aging” and accelerating age-related pathologies.

At EquiliBio, we’re developing targeted immune-modulating solutions to keep inflammation in check, protect long-term health, and redefine what healthy aging can look like. Because extending lifespan matters… but improving the years we live matters even more.

The Inflammation Problem

As we grow older, the immune system gradually enters a state of persistent activation. This state, called “inflammaging,” disrupts tissue repair, decelerates biological functions, and contributes to frailty, metabolic imbalances, and reduced physiological resilience.

Individually, modern medicine has made remarkable progress treating age-related diseases, but the underlying inflammatory biology remains largely unaddressed.

Targeting inflammation represents a powerful opportunity to improve health-span, not just life-span — shifting care from reactive to preventative, and from late-stage treatment to early, proactive intervention.

Our Approach

Some of the most important drivers of chronic inflammation are cytokines, the messenger proteins immune cells use to talk to each other. Today they can mostly only be blocked with injected antibodies. We’re developing small, ring shaped molecules that can be taken as a pill and act precisely where these inflammatory signals are switched on.

Chameleonic macrocycles

Ring shaped molecules that change shape: folded to pass through the gut, open to grip the large protein surfaces ordinary pills can't reach.
AI guided design

AI assisted virtual screening and molecular modelling search large chemical libraries on computer, so only the most promising molecules are made in the lab.
Precise, not broad

Aimed at the exact point where a pro-inflammatory signal is switched on, to calm chronic inflammation while keeping the body's defences against infection.
Biomarker driven

Measuring early whether a molecule reaches its target and calms inflammatory signalling in human cells and blood.

The goal is simple: Develop safe, effective interventions that help the body maintain balanced inflammation, preserve function, and age more slowly.

Research Pipeline

We’re developing oral, targeted modulators of pro-inflammatory cytokine signalling, designed for safe, long term use in healthy aging. Our first programme is in discovery, using AI guided screening to identify chameleonic macrocycles for synthesis and lab testing.